Feb 12
5
Statin Drugs for Cholesterol Lowering won’t Necessarily Save Your Life
In January of 2008 there was some unsettling news that came from the FDA about the risks of the cholesterol lowering medication Vytorin (combination of Zetia (Ezetimibe) and the statin drug Zocor (simvastatin)). Data from the Enhance trial that was not previously revealed by the manufacturer, Merck/Schering-Plough, showed that the combination drug did not reduce atherosclerotic plaque any better than the generic drug, statin simvastatin, when given alone.
Liver Cancer
In fact, if anything Vytorin seemed to make it worse, atherosclerotic plaque although it had a greater effect on lowering cholesterol. Vytorin has also been associated with an alarming increase in risk of liver cancer. Other studies have shown a slight increase in the risk of cancer, especially with the use of high dose statins to bring cholesterol down to very low levels. Statins can also cause liver damage, depression, memory problems, and joint pain. They can also cause damage to the muscle tissue which results in muscle pain. In rare cases this can lead to a breakdown of themuscle tissue which results in kidney failure. Zetia can headache, dizziness, diarrhea, muscle and joint pain, and more rarely jaundice, gall stones or inflammation of the pancreas.
Bottom line? The drugs you are taking to prevent heart disease may not be as useful as you think, and in some cases may be doing more harm than good. Let the buyer beware.
Liver Cancer Statin Drugs for Cholesterol Lowering won’t Necessarily Save Your Life
Statin Drugs for Cholesterol Lowering won’t Necessarily Save Your Life
Liver Cancer
Statin Drugs for Cholesterol Lowering won’t Necessarily Save Your Life Liver Cancer